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Abstract
Background: Children with severe malnutrition who develop shock have a high mortality. Contrary to
contemporaneous paediatric practice, current guidelines recommend use of low dose hypotonic fluid resuscitation
(half-strength Darrows/5% dextrose (HSD/5D). We evaluated the safety and efficacy of this guideline compared to
resuscitation with a standard isotonic solution.
Methods: A Phase II randomised controlled, safety and efficacy trial in Kenyan children aged over 6 months with
severe malnutrition and shock including children with severe dehydration/shock and presumptive septic shock
(non-diarrhoeal shock). Eligible children were randomised to HSD/5D or Ringer’s Lactate (RL). A maximum of two
boluses of 15 ml/kg of HSD/5D were given over two hours (as recommended by guidelines) while those
randomised to RL received 10 ml/kg aliquots half hourly (maximum 40 ml/kg). Primary endpoint was resolution of
shock at 8 and 24 hours. Secondary outcomes included resolution of acidosis, adverse events and mortality.
Results: 61 children were enrolled: 41 had shock and severe dehydrating diarrhoea, 20 had presumptive septic
shock; 69% had decompensated shock. By 8 hours response to volume resuscitation was poor with shock
persisting in most children:-HSD/5D 15/22 (68%) and RL14/25 (52%), p = 0.39. Oliguria was more prevalent at 8
hours in the HSD/5D group, 9/22 (41%), compared to RL-3/25 (12%), p = 0.02. Mortality was high, HSD/5D-15/26
(58%) and RL 13/29(45%); p = 0.42. Most deaths occurred within 48 hours of admission. Neither pulmonary
oedema nor cardiogenic failure was detected.
Conclusions: Outcome was universally poor characterised by persistence of shock, oliguria and high case fatality.
Isotonic fluid was associated with modest improvement in shock and survival when compared to HSD/5D but
inconclusive due to the limitations of design and effectiveness of either resuscitation strategy. Although isotonic
fluid resuscitation did not result in cardiogenic heart failure, as previously feared, we conclude that the modest
volumes used and rate of infusion were insufficient to promptly correct shock. The adverse performance of the
recommended fluid resuscitation guideline for severe malnutrition should prompt clinical investigation of isotonic
fluids for resuscitation of compensated shock, defining rate and volumes required to inform future guidelines.
Trial Registration: The trial is registered as ISCRTN: 61146418.
Background
Severe malnutrition is a common cause of admission to
hospital in young children in Africa and outcome
remains poor. The World Health Organization (WHO)
10-step treatment has improved case fatality, in some
settings, to under 5% [1-3], however, in African hospitals
implementation of the same guideline has achieved
poorer results with numerous reports of unacceptably
high case fatality rates [4,5]. At our hospital on the Ken-
yan coast, we have recently reported that mortality rates
in children with severe malnutrition, treated in accor-
dance with WHO guidelines, were 20%. Thirty percent
of the fatalities occurred within 48 hours of admission* Correspondence: kmaitland@kilifi.kemri-wellcome.org1KEMRI-Wellcome Trust Research Programme, Centre for Geographic
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and many had signs suggestive of hypovolaemic shock
including children with severe dehydrating diarrhoea [4].
WHO malnutrition guidelines advocate strict avoid-
ance of intravenous fluids and restrict the use of fluid
resuscitation to children with advanced features of
shock [1,6,7]. Fluid resuscitation is recommended only if
all of the following parameters are present- a weak, fast
pulse, cold peripheries, a capillary refilling time (CRT)
of > 3 seconds plus signs of impaired consciousness
(WHO malnutrition shock criteria) [6,7]. Ordinarily,
these features would be considered by paediatric life-
support providers as constituting a very advanced state
of shock, when outcome is generally poor. For children
fulfilling these criteria, preferential use of low-volume
hypotonic fluids (0.45% sodium content) is recom-
mended since it is commonly considered that malnour-
ished children are at increased risk of developing
congestive heart failure and sodium and water overload
[8]. There is substantial debate over best treatment with
scientific rationale advanced to justify this highly pro-
moted WHO guideline, but what is clear is that the evi-
dence base is weak and unsupported by the relevant
physiological studies or clinical trials [8,9].
The criteria for shock and fluid management recom-
mendations are a distinct departure from contemporary
paediatric practice which advocates the recognition of
an early phase of shock (compensated shock) and rapid
correction with isotonic resuscitation fluids to restore
circulatory volume. These have been implemented
widely and prospectively evaluated. Children who were
managed according to American College of Critical
Care Medicine/Pediatric Advanced Life Support
(ACCM-PALS) guideline [10,11] that received up to 60
mls/kg of isotonic fluid resuscitation over the first hour
by community physicians or para-medics show a nine-
fold reduction in mortality compared to cases who were
not managed in accordance with these recommenda-
tions [12]. Importantly, these guidelines are widely prac-
ticed throughout the world, largely by non specialists
but are still not standard practice in many African hos-
pitals where they have yet to be evaluated.
In light of the high mortality of children with severe
malnutrition and features of shock [4] we undertook a
prospective evaluation of volume resuscitation in a pilot
study (Fluid resuscitation In Malnutrition Trial: FIM).
The FIM trial was conducted to examine the safety and
efficacy of isotonic (0.9% sodium content) low volume
fluid resuscitation and current WHO resuscitation pro-
tocol using low-volume hypotonic fluids. In this trial, we
used isotonic fluids very cautiously, using similar
volumes to those used WHO resuscitation protocol. In
the absence of any safety data for this study population,
the administration of appropriate volume resuscitation,
as recommended internationally, was not incorporated
in the design before the generation of the relevant hae-
modynamic data for which the risks and benefits could
be assessed.
Methods
Participants
The study was conducted on the paediatric high depen-
dency unit (HDU) Kilifi District Hospital (KDH), situ-
ated on the coast of Kenya. The amenities and expertise
of the personnel enable full hemodynamic monitoring in
critically ill children. However, no artificial ventilation
facilities are available. Medically qualified members of
the Kenya Medical Research Institute (KEMRI) team
completed a standard admission questionnaire and
examination at admission to hospital. Severe malnutri-
tion (SM) was defined as any of: weight for height
z-score <-3 or weight for height percentile 70%; or mid-
upper arm circumference (MUAC) < 11.0 cm; or
oedema involving at least both feet (kwashiorkor).
MUAC was measured with a cloth (non-stretchable)
measuring tape, weight with an electronic scale (Soehnle
model 7300, CMS Instruments, UK), and length using a
measuring board of standard design.
Children were eligible for inclusion in the study if they
were aged over 6 months with severe malnutrition with
evidence of shock. Prior to this trial we undertook a
pilot evaluation of the WHO shock and fluid resuscita-
tion guidelines in 8 children which resulted in univer-
sally fatal outcome. The chief reasons were considered
to be that the WHO malnutrition shock criteria identi-
fied children with very advanced stages of shock and
high risk of mortality. In addition was the poorly toler-
ated early initiation of feeding which is recommended
by WHO guideline in children immediately after fluid
resuscitation. For the Phase II feeding was withheld
until children were stabilised and were able to tolerate
nutritional supplementation. The stringent WHO shock
criteria were amended to include children with one or
more of the following: CRT > 2 seconds, lower limb
temperature gradient, weak pulse volume, prolonged
capillary refill > 2 seconds, deep ‘acidotic’ or ‘Kussmaul’
breathing, creatinine >80 μmol/L, or depressed con-
scious state (prostration (inability to sit up if aged >8
months) if present after correction of hypoglycaemia.
Temperature gradient was defined as cooler extremities
to warmer core and assessed by running the back of the
palm of the hand up the lower limb. The radial pulse
was used to assess pulse volume. Children were
excluded if they had any of the following: severe anae-
mia (haemoglobin ≤5 g/dL); pulmonary oedema (defined
as clinical evidence of presence of fine crepitations in
both lung fields plus oxygen saturations < 90% in air);
raised intra-cranial pressure or known congenital heart
disease.
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Individual informed written consent was obtained
from parents/guardians before randomisation. When the
situation was judged as an emergency, ethical approval
permitted initial verbal assent followed by deferred
informed consent once the child had been stabilised.
Random allocation was assigned by the use of sealed
cards and study interventions were not masked. Oxford
University was the sponsor of the trial. The FIM trial is
registered as ISCRTN: 61146418. Ethical approval for
the study was obtained from the national ethics commit-
tee of KEMRI and OXTREC (Oxford Research Ethical
Committee).
Interventions
Two groups were considered. Severe dehydration/
shock (shock and severe dehydrating diarrhoea defined
as ≥6 watery stools per day) who were randomly
assigned to receive either WHO fluid resuscitation
regime (half-strength Darrow’s in 5% dextrose (HSD/
5D)) or Ringers Lactate (RL) and Presumptive septic
shock (non diarrhoeal shock) randomised to one of
three fluid resuscitation intervention arms: WHO fluid
resuscitation regime, Ringers Lactate or 5% human albu-
min solution (HAS).
The WHO fluid resuscitation regime
initial bolus of 15 mls/kg of HSD/5D over one hour.
Repeat bolus was given once (15 ml/kg of HSD/5D over
1 hour) if some improvement in features of shock
noted. If no improvement was seen, they received 10
mls/kg whole blood transfusion over 3 hours.
Ringers Lactate or albumin resuscitation
initial bolus of 10 ml/kg over 30 minutes, repeated only
twice over one hour (i.e. up to 30 ml/kg in total) if clini-
cal reassessment demonstrated any of the following fea-
tures of shock: CRT > 3 s, weak pulse volume,
temperature gradient or hypotension (systolic blood
pressure (SBP) <80 mmHg)).
Additional boluses (10 mls/kg over one hour) were
only permitted if oliguria (<0.5 mls/kg/hour) or hypo-
tension (systolic pressure <80 mmHg) developed (20
mls/kg over one hour). Maximum bolus volumes given
were 40 ml/kg. At each clinical review children were
assessed for clinical resolution of shock and examined
for signs of pulmonary oedema (if present further
boluses withheld and treated with diuretics). No invasive
monitoring, such as central venous pressure (CVP) mea-
surement, was used. The children did not receive ino-
tropes, vasopressors, or hydrocortisone. Other than the
initial fluid boluses additional intravenous fluids boluses,
intravenous rehydration for children with severe diar-
rhoea or maintenance fluids were not given (as per
guideline recommendation). The only exception was if
the child was intolerant to feeding when low volume
maintenance was provided. Children were continuously
and non-invasively monitored for heart and respiratory
rate, oxygen saturation using a multi channel Siemens®
monitor and hourly for blood pressure and urine output
then every 4 hours after 8 hours. At admission blood
gases, plasma biochemistry, and haematology were
assessed and reassessed at 8- and 24-hours post-admis-
sion. Blood and urine were cultured at admission on all
children and lumbar puncture, where indicated. Adher-
ence to protocol was validated by an internal but inde-
pendent monitoring team. The trial was monitored
three times during execution.
Standard management of severe malnutrition
In all other respects children were treated according to
WHO guidelines [13]. Hypoglycaemia (blood glucose <3
mmols/L) was treated with 5 mls/kg of 10% dextrose.
Malnutrition oral rehydration solution (ReSoMal) [13]
was given to children with significant diarrhoea (>6
loose stools/day) rather than intravenous rehydration
irrespective of the level of clinical dehydration [14]. All
children received intravenous ampicillin (50 mg/kg four
times per day) and intramuscular gentamicin (7.5 mg/kg
once daily) for at least 5 days. Ceftriaxone was used as
second line antimicrobials or when directed by micro-
biological results. The macro and micro-nutritional
aspects of management are covered in a previous publi-
cations [4]. Early nasogastric feeding, recommended by
the guideline immediately after resuscitation was with-
held, and children placed on maintenance intravenous
dextrose fluids until children were stabilised, intestinal
ileus excluded and tolerance of oral feeds established.
Objectives
Primarily to establish whether hypovolaemic shock
could be safely corrected by volume replacement Ring-
er’s Lactate (an isotonic crystalloid), Human albumin
solution (HAS) or HSD/5D (hypotonic crystalloid). The
secondary objective was to assess the frequency of ser-
ious side effects, namely pulmonary oedema.
Outcomes
Primary outcome measurement was the resolution of
features of shock at 8 and 24 hours. Resolution of
shock, defined as the absence of all of: severe tachycar-
dia (heart rate >160 beats per minute), CRT > 2 s or oli-
guria (urine output<1 ml/kg/hr). Secondary outcomes
included incidence of adverse events (such as fluid over-
load) and mortality.
Sample size
The null hypothesis was that there is no difference in
the safety profile or effect on physiological parameters
of shock using Ringer’s Lactate, HAS (isotonic crystal-
loids), or HSD/5D (hypotonic crystalloid) for fluid
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resuscitation. Our aim was to generate data to address
the trial objectives balanced against the desire to mini-
mize exposure of children to a therapeutic intervention
for which there is no published data. We aimed to
recruit 90 children: 45 to receive Ringer’s Lactate, 45 to
receive HSD/5D, and 20 to receive HAS. The numbers
were chosen to provide sufficient information on hae-
modynamic response and adverse events to the two
fluid management regimes to understand potential effi-
cacy of each regime rather than compare the two
strategies.
Statistical methods
Dichotomous and categorical variables were created
from continuous variables. Derived variables were cre-
ated from clinical factors defined by Paediatric
Advanced Life Support (PALS) guidelines as indicating
a definitive need for urgent therapeutic intervention
and for laboratory variables. We defined the following:
severe tachycardia (>160 beats/minute); bradycardia
(<60 beats/min); hypoxia (oxygen saturation <95% on
air or unable to record by pulse oximeter); tachypnoea
(respiratory rate>60 breaths/minute at any age);
hypothermia (axillary temperature < 35°C); capillary
refill ≥3 seconds; hypotension (systolic blood pressure
<70 mmHg or unrecordable); acidosis (base deficit >8);
elevated creatinine (>80 μmols/l); hypoglycaemia (<3.0
mmols/l); hyperglycaemia (>10 mmols/l); hypokalaemia
(<3 mmols/l); hyperkalaemia (>5.5 mmols/l) or hypo-
natraemia (<125 mmols/l). Means and standard devia-
tions were calculated for continuous variables using
the student t-tests. Non-normally distributed data were
compared using Sign-rank test and Kruskal-Wallis.
Proportions were compared using chi-square and Fish-
er’s exact tests as appropriate. We also used Kaplan
Meier survival analysis to compared time to event
(death). The area under curves (AUC) were calculated
for serial measurements and their medians compared
using Wilcoxon-Ranksum and Kruskal-Wallis tests.
We employed AUC in order to compensate for con-
founding effect of early mortality, hence missing obser-
vations, leading to biases in the highest risk group and
resulting imbalance within the survivors [15]. All ana-
lyses were by intention to treat.
Results
Eighty six severely malnourished children with shock were
assessed for eligibility. Of these 25 were ineligible for
recruitment; 61 were enrolled (Figure 1: trial flow). Forty
children had hypovolaemic shock secondary to dehydrat-
ing diarrhoea and 21 had hypovolaemic shock, presumed
to have been secondary to sepsis or a sepsis-like syndrome.
None of the children excluded had cardiogenic shock or
pulmonary oedema. Only six children with presumptive
septic shock received 4.5% albumin. Baseline characteris-
tics (and haemodynamic responses) of these 6 individuals
were similar to the other participants in the sepsis group
that were randomised to the other two investigational
fluids but are not summarised due to small numbers.
Recruitment commenced in November 2006 and the deci-
sion to discontinue recruitment was made after interim
review of the safety data in May 2008.
Numbers analysed
Sixty one children were recruited, 26 received HSD/5D,
29 received RL and 6 HAS. Forty had severe dehydra-
tion/shock diarrhoea (RL = 22, HSD/%D = 19) and 21
has presumptive septic shock (RL = 8, HSD/%D = 7,
HAS = 6). By intention to treat, we report results of pri-
mary outcome comparisons between 26 children who
received HSD and 29 who received RL. Owing to the
small numbers who received HAS, we only report mor-
tality and safety outcome for those treated with HAS.
Baseline data
The median age of the trial participants was 15 months
(interquartile range; 12, 23); 64% (35) had severe maras-
mus and 21% (13) had features of oedematous malnutri-
tion (kwashiorkor). Overall, 75% (41) fulfilled the strict
WHO definition of advanced shock. Baseline character-
istics and disease severity indices were similar across the
fluid intervention arms (Table 1). Children with shock
and dehydration secondary to diarrhoea 32/40 (80%)
had a higher frequency of WHO severe malnutrition
shock definition than children with presumptive sepsis,
10/21 (48%) (p = 0.01). The diarrhoeal group were also
more severely acidaemia (pH 7.22 ± 0.19 versus 7.34 ±
0.17; p = 0.03). The mean volume for the bolus infused
in children randomised to HSD/5D was 30 ml/kg (stan-
dard deviation ± 10 ml) and 39 ml/kg (standard devia-
tion ± 22 ml) in those receiving RL.
Primary outcomes
Resolution of shock
By 8 and 24 hours the proportion of children with shock
in both RL arm and HSD/5D was considerable, 14/25
(56%) and 15/22(68%) respectively. A larger decline in
the proportion with shock was observed in RL recipients
compared to HSD/5D particularly in the diarrhoeal
group however these differences were not significant at
any time point (Table 2 and Figure 2).
Tachycardia
Persistent tachycardia (an index of unresolved shock)
was common at 8 and 24 hours, was present in 10/47
(21%) and 12/39(31%) children respectively, but was
more prevalent in the HSD/5D arm (p = 0.04) (Table 2).
Median AUC of the heart rates were similar for both
study interventions (Kruskal-Wallis: c2 = 0.3; p = 0.59).
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Oliguria
Since renal failure was excluded as entry criteria we used
adequate urinary output as a gold standard for successful
fluid resuscitation; with oliguria being a marker of persis-
tent, severe shock. Oliguria was common in both interven-
tion arms but more prevalent in the HSD/5D arm at 8
hours (9/22; 41%) than in those receiving RL (3/25; 12%)
p = 0.05. By 24 hours, oliguria was still common children
receiving HSD/5D regime but no different from RL group
(Table 2 and Figure 3). Median AUC for the hourly urine
output (ml/kg/hr) was lower in HSD/5D recipients (51;
IQR, 36, 116) than RL recipients (101; IQR, 63, 141)
(Kruskal-Wallis c2 = 4.6; p = 0.03). Mean serum creatinine
levels and proportion with elevated creatinine were similar
in both arms over the course of admission.
Secondary outcomes
Respiratory distress
Severe tachypnoea was less common in the children
receiving RL than HSD/5D at both 8 and 24 hour.
Mean respiratory rate was greater in the HSD/5D arm
than RL arm at 8 and 24 hours (p = 0.002) (Table 2).
Overall, there was a trend towards higher median AUC
of respiratory rates was noted in those who died (2262;
IQR, 1938, 2897) compared to survivors (2015; IQR,
1547, 2391) (Kruskal-Wallis: c2 = 3.6; p = 0.06).
Resolution of base deficit
The base deficit at 8 hours in children receiving HSD/
5D was lower than the RL (p = 0.04) but no difference
was noted in survivors to 24 hours (p = 0.81). Many
trial participants remained severely acidotic (base deficit
>15 mmol/L) over the first 24 hours (Table 2). Compar-
ing the admission and 24 hours base deficit (% change
over baseline) we noted that the mean reduction was
greater in those who received RL (8.5 mmol/L; p =
0.002) as compared HSD/5D (1.0 mmol/L; p < 0.87).
Mortality
Overall, 31/61(51%) children died; HSD/5D (15/26 =
58%); RL (13/29 = 45%) and HAS (3/6 = 50%) (p =
0.62). The difference in mortality between those receiv-
ing HSD/5D and RL was non-significant (p = 0.34). Of
the children who died, 84% (26/31) fulfilled the WHO
malnutrition shock definition at admission. Case fatal-
ity rate in this high risk subgroup was 59% (26/44),
irrespective of allocated intervention, and was asso-
ciated with an increased risk of death (Risk Ratio =
2.0, 95% confidence interval 0.92-4.36; P = 0.05) com-
pared to those that did not have these criteria. In the
group with severe diarrhoea mortality was higher 13/
19(68%) in those receiving HSD/5D than in those
receiving RL 9/22(43%) p = 0.11. Case fatality in the
group with presumptive septic shock was 2/7(43%) for
HSD/5D was and 4/8(50%) for RL (p = 0.61). Thirteen
(42%) of the fatalities were HIV positive, 14(45%) were
HIV negative, and 4 (13%) declined HIV tests. Infec-
tion with HIV did not significantly increase the risk of
death (odds ratio 1.18; 95% confidence interval 0.38,
3.72; p = 0.76). Nine (29%) of the deaths were in
Figure 1 Trial flow
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children who had kwashiorkor, case fatality was 69%
(9/13) in children with kwashiorkor, irrespective of
intervention arm. Kwashiorkor was associated with a
non significant increased risk of death (odds ratio 2.2;
95% confidence interval 0.7, 10.1; p = 0.14).
Time to death
Thirty nine percent (12/31) of the deaths occurred within
24 hours of recruitment while 52% (16/31) of fatalities
occurred within 48 hours of enrolment. On Kaplan Meier
survival analysis, we found no significant difference in the
Table 1 Baseline characteristics for children in Phase II trial
HSD/5D (n = 26) RL (n = 29) P
Male, n (%) 15(58) 17(59) 0.94
Age, months (IQR) 15(14) 16(6) 0.41
Feature N (%)
MUAC, mean ± SD 10.4(1.4) 10.0(1.9) 0.43
WHZ, mean ± SD -3.4(1.3) -3.9(1.0) 0.18
Severe wasting 14(54) 21(72) 0.15
Kwashiorkor 8(31) 4(14) 0.19
Desquamation 2(8) 1(3) 0.60
HIV positive* 9(35) 14(48) 0.65
Severity N (%)
Deep breathing 18(69) 21(72) 0.88
Hypoxia (<95% or unrecordable) 3(12) 3(10) 0.57
Tachypnoea (>60 brpm) 16(62) 13(45) 0.22
Severe tachycardia (>160 bpm) 11(42) 8(28) 0.25
Capillary refill ≥3 s 15(58) 16(55) 0.53
Weak pulse volume 13(50) 19(66) 0.24
Bradycardia (<60 bpm) 0 0
Temperature gradient 17(65) 23(79) 0.25
Hypotension (SBP <70 mmHg) 5(19) 5(17) 0.44
WHO shock criteria 18(69) 23(79) 0.39
Hypothermia (ax. temp < 35°C) 0 0
Hydration
Reduced skin turgor 8(31) 16(55) 0.07
Sunken eyes 11(42) 19(66) 0.08
Consciousness
Coma 3(12) 4(14) 1.00
Prostration 15(58) 13(45) 0.34
Abnormal biochemistry N (%)
Acidosis (base deficit >8) 12(46) 20(69) 0.09
Creatinine (>80 μmols/L) 13(50) 13(49) 0.70
Hypokalaemia(<3.0 mmols/L) 16(62) 19(66) 0.76
Hyperkalaemia(>5.5 mmols/L) 2(7) 0 0.22
Hyponatraemia(<125 mmols/L) 4(15) 3(10) 0.58
Hypernatraemia (>145 mmols/L) 3(12) 3(10) 1.00
Hypoglycaemia(<3.0 mmols/L) 1(4) 4(14) 0.36
Hyperglycaemia(>10.0 mmols/L) 0 0
Mean laboratory variable, ±SD
Haemoglobin, g/dl 8.7(2.2) 8.9(1.9) 0.67
pH 7.25(0.25) 7.26(0.13) 0.79
Base deficit, mmol/L 14(11) 17(6) 0.26
Creatinine, μmol/L 107(78) 95(58) 0.53
Bicarbonate, mmol/L 14(13) 10(5) 0.16
*7 children were missing HIV test results: 4(15%) HSD/5D; 3(10%) RL arms.
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time to death when any of the intervention fluids are used
for resuscitation (logrank test: combined (p = 0.42).
Severe adverse events
No child developed clinical features of pulmonary
oedema or allergic reaction (to HAS) during the course
of study observation. Frusemide or other diuretics were
not required or prescribed during the trial. There were
no differences in the mean sodium concentration at
admission (133[SD ± 11] versus 134 [10]; p = 0.81), 8
hours (134 [10] versus 139 [10]; p = 0.09), and 24 hours
(138 [9] versus 140 [9]; p = 0.47) between those who
received HSD/5D and RL respectively.
Discussion
Our observations of the WHO severe malnutrition shock
management protocol using half-strength Darrow’s in 5%
dextrose (HSD/5D) in the pilot study and Phase II trial
indicate a very high mortality when applied rigorously
and with some improvement when applied to a lower
risk shock group and with changes to supportive man-
agement strategies (100% and 58% respectively). Shock
was inadequately corrected evidenced by persisting shock
in 78% and oliguria in 40% of survivors to 24 hours dur-
ing the RCT. Cautious fluid resuscitation using low dose
isotonic solution (RL) was shown to be safe, with moder-
ately better resolution of some, but not all, of the haemo-
dynamic parameters of shock, but without significant
survival advantages. By 24 hours 50% of children in the
RL arm had persisting feature of shock, including 24%
with oliguria. Cardiogenic failure, evidence by pulmonary
oedema, was not observed for any of the fluid resuscita-
tion strategies in this trial.
Table 2 Primary and Secondary outcomes
Time HSD/5D (n = 26) RL (n = 29) p
PRIMARY OUTCOMES
Number with shock, n/N(%) 8 h 15/22(68) 14/25(56) 0.39
24 h 14/18(78) 14/25(56) 0.14
Oliguria (<1 ml/kg/hour), n/N(%) 8 h 9/22(41) 3/25(12) 0.02
24 h 8/18(44) 6/25(24) 0.16
Tachycardia (>160 bpm), n/N(%) 8 h 6/22(27) 4/25(16) 0.34
24 h 8/14(44) 4/25(16) 0.04
Creatinine, mean(± standard deviation) 8 h 112(85) 104(60) 0.73
24 h 89(56) 112(87) 0.39
SECONDARY OUTCOMES
Tachypnoea (>60 br.pm), n/N(%) 8 h 7/22(32) 2/25(8) 0.04
24 h 7/18(39) 3/25(12) 0.04
Base deficit, mean(± standard deviation) 8 h 10(13) 15(7) 0.16
24 h 12(8) 8(9) 0.38
In-hospital mortality, n/N (%) 15/26(58) 13/29(45) 0.34
Figure 2 Proportion of children in shock over 24 hours of
observation: A higher proportion of children randomised to HSD/
5D (WHO solution) remained in shock compared those receiving RL
over 24 hours of observation.
Figure 3 Proportion of children with oliguria over 24 hours of
observation.
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The high overall mortality, 51% and inadequate cor-
rection of shock in all study arms, resulted in a decision
to prematurely terminate the trial, and followed consul-
tation with the external safety monitors. Owing to the
safety concerns over the use of fluid resuscitation in
children with severe malnutrition the compromise
design of the trial including low to modest volume fluid
expansion and a protocol with little flexibility over addi-
tional boluses. Nor did the design purposely comply
with either the WHO guideline for non-malnourished
children or international accepted paediatric practice.
As the trial progressed the absence of any clear evi-
dence of cardiogenic failure and volume overload
coupled with the high mortality raised anxieties over
the rationale for withholding standard international pae-
diatric practice guidelines. Moreover, there was reluc-
tance by the clinical team to continue enrolment into a
trial with a compromised intervention strategy and a
concern that adoption of the standard approach to fluid
resuscitation was increasingly becoming the more justi-
fiable approach.
The significant departure of the WHO malnutrition
shock treatment recommendations from accepted pae-
diatric practice without adequate physiological or clini-
cal evidence is a major concern. Early and aggressive
resuscitation of children with isotonic fluids has shown
substantial survival benefits. For example, it has been
demonstrated that for every hour that shock is left
uncorrected leads to a doubling of mortality [16,17].
This latter observation has relevance to our experience
and results of our FIM trial. The pilot and the FIM trial
included severely malnourished children diagnosed and
managed in accordance with current WHO guideline in
whom there was a universally fatal outcome indicating
that intervening at this stage is ‘almost too late’. With
the amendment to entry criteria, where shock was
defined using a less stringent definition, we found a
lower but still unacceptably high mortality.
The decision to undertake this trial and its early ter-
mination reflect the difficulties encountered when
strongly promoted international guidelines might be
considered at odds with current best clinical practice,
albeit largely derived from experience in quite different
geographical and cultural settings. We demonstrated
that even in children with kwashiorkor, the outcomes
were not worse in those receiving isotonic fluids. Our
findings are consistent with findings of a recent study
from Bangladesh where children with severe malnutri-
tion and cholera safely tolerated up to 100 ml/kg of iso-
tonic fluid (cholera saline) given 6 hours [18]. Although
cholera represents a special case, with disproportionately
huge fluid loses, the findings of both these studies chal-
lenge the notion that children with severe malnutrition
have myocardial dysfunction together with sodium (and
water) retention [19] rendering them susceptible to inci-
pient cardiogenic failure and inability to cope with rapid
volume expansion using isotonic fluids [8]. Studies that
have reported reduced mortality following adoption of
the fluid management guidelines, and hence used to jus-
tify the current fluid recommendations, have involved
concurrent introduction a whole care package and
therefore have many confounders since they were not
designed to answer the specific question of fluid resusci-
tation [4,20-23]. Even these studies have studies have
reported inconsistent findings.
The origins of these concerns date back to studies
from 1960s and 1970s indicating that children with
severe malnutrition have a state of ‘reductive adaptation’
with sodium and water retention, expanded extracellular
compartment, myocardial atrophy and a ‘hypocirculatory
state’ said to recover on nutritional rehabilitation if
intravenous fluids are avoided [2,24-29]. Supportive evi-
dence was drawn from radiographic studies showing
reduced cardiothoracic ratios on x-rays, autopsy studies
showing diminished heart size, and histological changes
such as interstitial oedema and myocardial atrophy
[30,31]. Whereas other observers concluded that the
heart is reduced in size in concordance with the skeletal
musculature [28,29] and both systolic and diastolic func-
tions are well preserved, indicating that response to fluid
expansion should be similar to non-malnourished chil-
dren [32,33]. The observation of the expanded extracel-
lular space (ECF) was challenged by Fronius suggesting
that the apparent expansion of ECF was spurious and
resulted from the relative changes in the intracellular
compartment, which disproportionately contracts in
severe wasting [34]. What is clear from the literature is
that very few studies linked clinical status, physiological
investigation and response to treatment in representative
cohorts of children with severe malnutrition. Few have
drawn on modern technology and contemporary under-
standing of paediatric critical illness to study myocardial
status and haemodynamic response to fluid expansion.
Our reading of the literature and guidelines suggests
that there is substantial confusion with respect to the
understanding of the complex interaction of myocardial
dysfunction and circulatory failure (hypovolaemia), well
recognised in paediatric critical illness, with that of
heart failure and circulatory overload when the termi-
nology is frequently used synonymously [26]. Much of
the work examining total body sodium concentration
and impaired kidney function were usually conducted in
inadequately clinically described study cohorts and
focused on single organ pathophysiology [35-38]
unlinked to haemodynamic status or whole body phy-
siology. This may lead to different interpretation of the
findings, for example, in the early stages of shock or
dehydration sodium and water retention are a common
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compensatory mechanism in severe illness with circula-
tory impairment [39].
In the absence of physiological studies it is difficult to
challenge these viewpoints, which underpin the scientific
rationale advanced for the current WHO fluid resuscita-
tion guidelines. We conclude that since the assumed
risks of heart failure did not materialise in our trial we
suggest that this treatment priority may have been given
disproportionate emphasis and is based on insufficient
scientific evidence to justify withholding standard fluid
resuscitation practice.
Our study, together with recent trial in malnourished
Bangladeshi children, provide new findings to add to the
scientific literature and extend the debate with regards
to fluid resuscitation in children with severe malnutri-
tion [8,40-44]. The high mortality, persistence of shock
and oliguria suggests that more aggressive treatment
may be warranted. Whilst research is undertaken to
define the most appropriate guideline, the most prag-
matic approach for clinicians when faced with this very
challenging clinical scenario is probably to follow the
standard of care outlined by the WHO for non-mal-
nourished children [6,7,11,45,46]. However, caution will
still be required while introducing the use of higher
volumes of isotonic fluids than presently recommended
by WHO malnutrition guidelines [8]. Our study also did
not include a systematic assessment myocardial dysfunc-
tion and therefore relied on clinical diagnosis of fluid
overload. Newer techniques for monitoring haemody-
namic response to fluids, which are easy to learn, non-
invasive, reliable and reproducible are now available and
could be easily used in low resource settings [47]. These
techniques offer assessment of myocardial function at
presentation together with monitoring of haemodynamic
response to fluid expansion. Finally, our findings do not
exclude further consideration of colloids in children
complicated by septic shock, since the HAS arm was
too small to draw any meaningful conclusions.
Conclusion
Despite many shortcomings, this is the first randomised
controlled trial comparing isotonic fluids to one of the
hypotonic fluids recommended by WHO for treatment
of shock in children with severe malnutrition. Volume
expansion using isotonic fluids were at least as safe as
hypotonic solutions recommended in the current guide-
line since cardiogenic failure did not complicate their
use. Shock was not adequately corrected by any of the
fluid strategies and poor outcome lead us to conclude
that the volumes and rate of correction of hypovolaemia
currently recommended and used in this trial are inade-
quate. Although use of isotonic fluid was associated
with modest improvement in shock and survival when
compared to HSD/5D, these results remain inconclusive.
Future research should consider standard WHO or
international fluid resuscitation recommendations in
these children.
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